Nausea: Clinical Trials

110 trials for Nausea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

110 completed. 110 Phase 3, 18 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3110Completed 110
Phase 218Completed 18

Follow Nausea: new trials by email Literature Review of Nausea trials Research Report on Nausea

Trials (filtered) newest first · largest first

All 110 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients
Aprepitant 40mg, Placebo - Nausea and Vomiting, Postoperative, Prevention
Phase 3CompletedCentre hospitalier de l'Université de Montréal (CHUM)2602026-02-272026-08-27
A Clinical Study to Assess the Effectiveness of ENO Lime in Participants With Ajeerna Vyadhi (Acidity, Acid Indigestion, Indigestion, and Associated Nausea)
ENO Lime - Indigestion Acid, Indigestion
Phase 3CompletedHALEON402025-08-202025-09-17
Comparison of Dexmedetomidine and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy
Dexamedomedine, Dexamethasone - Postoperative Nausea and Vomiting
Phase 3CompletedPatel Hospital, Pakistan682025-06-012026-02-23
HR20013 for Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents
HR20013 + dexamethasone + palonosetron placebo, Palonosetron + dexamethasone + HR20013 placebo - Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents
Phase 3CompletedFujian Shengdi Pharmaceutical Co., Ltd.7062024-09-032025-11-17
Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia
Itopride Hydrochloride 150 mg extended release tablets, Itopride Hydrochloride 50 mg film coated tablets - Functional Dyspepsia
Phase 3CompletedAbbott5642024-02-282026-04-03
An Evaluation the Effect of Superhydration Versus Dextrose 10% for Prevention of Post Operative Nausea and Vomiting After Laparoscopic Cholecystectomy (Prospective Randomised Controlled Study)
ringer lactate (20ml/kg), Dextrose 10% - Postoperative Nausea and Vomiting (PONV)
Phase 3CompletedAin Shams University2042024-02-252025-02-26
Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting
Aprepitant Injection, Aprepitant Injection Placebo - Postoperative Nausea and Vomiting
Phase 3CompletedQilu Pharmaceutical (Hainan) Co., Ltd.5182024-02-022025-04-23
Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients
Amisulpride Injection, Dexamethasone - Nausea and Vomiting, Postoperative
Phase 2 / Phase 3CompletedAcacia Pharma Ltd4532024-01-182025-06-25
Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis
Tradipitant - Idiopathic Gastroparesis, Diabetic Gastroparesis
Phase 3CompletedVanda Pharmaceuticals172024-01-092026-10-19
Dexamethasone at Night vs at Induction on PONV After Laparoscopic Cholecystectomy
At-night Dexamethasone, At-induction Dexamethasone - Postoperative Nausea and Vomiting, Postoperative Pain
Phase 2 / Phase 3CompletedMansoura University602023-10-082024-01-25
Intraperitoneal Dexamethasone, Dexmedetomidine, and Dexamethasone-Dexmedetomidine Combination on Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
normal Saline, Dexamethasone, Dexmedetomidine - Laparoscopic Cholecystectomy, Postoperative Nausea and Vomiting
Phase 3CompletedAl-Azhar University1202023-08-102025-06-18
Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data
Neuraxial Analgesia, Regional Block 1: Paravertebral, Perphenazine - Perioperative Optimization
Phase 3CompletedJennifer Holder-Murray33952023-05-152026-05-28
Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy
Ondansetron 8mg, Gabapentin - Post Operative Nausea and Vomiting, Sleeve Gastrectomy
Phase 3CompletedTanta University1002022-10-012025-04-17
THRIVE Feasibility Trial
Anesthetic technique Propofol TIVA, Anesthetic technique inhaled agent - Surgery--Complications, Anesthesia Complication
Phase 3CompletedWashington University School of Medicine3002022-09-292023-11-24
Baclofen in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery
Baclofen Tablets - Postoperative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy
Phase 2 / Phase 3CompletedTanta University1002022-08-222025-04-22
Postoperative Analgesic Effectiveness of Bupivacaine With and Without Dexmedetomidine in Patients With Abdominal Surgery
bupivacaine wound infilteration, Bupivacaine plus dexmedetomidine wound infilteration - Post Operative Pain, Bradycardia
Phase 2 / Phase 3CompletedSahiwal medical college sahiwal642022-02-202024-08-01
Anti-emetic Prophylaxis With or Without Dexamethasone
Fosaprepitant, tropisetron, and olanzapine-based antiemetic regimen, Fosaprepitant, tropisetron, olanzapine, and dexamethasone-based antiemetic regimen - Chemotherapy-induced Nausea and Vomiting
Phase 3CompletedHenan Cancer Hospital4422022-02-012024-10-10
Supplemental Perioperative Intravenous Crystalloids for Postoperative Nausea and Vomiting in Children Undergoing Oncological Surgery
Ringer's Lactate, normal Saline - Nausea and Vomiting, Postoperative
Phase 2 / Phase 3CompletedAlexandria University1002022-01-102022-12-20
Triple Therapy for Postoperative Nausea and Vomiting in Laparoscopic Gastrointestinal Surgery
palonosetron, dexamethasone, and fosaprepitant dissolved in 0.9% NaCl, palonosetron, dexamethasone, and 0.9% NaCl - C.Surgical Procedure; Gastrointestinal
Phase 3CompletedSixth Affiliated Hospital, Sun Yat-sen University11542021-04-272022-12-29
Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Hip Arthroscopy
Dexamethasone 4mg, NaCl 0.9% - Pain, Postoperative, Nausea, Postoperative
Phase 3CompletedBalgrist University Hospital602021-03-112023-09-25

Showing 20 of 110. Sign in to see all of them.

Narrower conditions

Vomiting (67)  ·  Postoperative Nausea and Vomiting (48)  ·  Pain (9)  ·  Pain, Postoperative (9)  ·  Breast Neoplasms (6)  ·  Gastroparesis (5)  ·  Neoplasms (5)  ·  Abdominal Pain (4)  ·  Hypotension (3)  ·  Agnosia (2)  ·  Anxiety Disorders (2)  ·  Diabetes Mellitus (2)  ·  Diarrhea (2)  ·  Dyspepsia (2)

Broader conditions

Pathological Conditions, Signs and Symptoms (110)  ·  Signs and Symptoms (110)  ·  Signs and Symptoms, Digestive (109)  ·  Pathologic Processes (51)  ·  Postoperative Complications (49)  ·  Vomiting (37)  ·  Neurologic Manifestations (27)  ·  Neoplasms (14)  ·  Neoplasms by Site (14)  ·  Pain (13)  ·  Digestive System Diseases (9)  ·  Gastrointestinal Diseases (9)  ·  Breast Diseases (6)  ·  Nervous System Diseases (6)

Interventions

Dexamethasone (29)  ·  Ondansetron (17)  ·  Granisetron (13)  ·  Palonosetron (12)  ·  Aprepitant (11)  ·  Calcium Dobesilate (8)  ·  Olanzapine (6)  ·  Sodium Chloride (5)  ·  casopitant (5)  ·  Gabapentin (4)  ·  Saline Solution (4)  ·  Acetaminophen (3)  ·  Hydrocodone (3)  ·  Metoclopramide (3)  ·  Promethazine (3)

Sponsors

Acacia Pharma Ltd (6)  ·  GlaxoSmithKline (5)  ·  M.D. Anderson Cancer Center (4)  ·  Alliance for Clinical Trials in Oncology (3)  ·  Charleston Laboratories, Inc (3)  ·  Merck Sharp & Dohme LLC (3)  ·  Tesaro, Inc. (3)  ·  Evoke Pharma (2)  ·  Gary Morrow (2)  ·  Helsinn Healthcare SA (2)  ·  Instituto Mexicano del Seguro Social (2)  ·  NCIC Clinical Trials Group (2)  ·  Odense University Hospital (2)  ·  Pfizer (2)  ·  Tanta University (2)

Countries

United States (48)  ·  Canada (11)  ·  France (11)  ·  Germany (11)  ·  Egypt (8)  ·  China (6)  ·  Pakistan (6)  ·  Belgium (5)  ·  Czechia (5)  ·  Hungary (5)  ·  Ireland (5)  ·  Philippines (5)  ·  Russia (5)  ·  Thailand (5)  ·  United Kingdom (5)

Top investigators

Dennis Vargo, MD (3)  ·  Alejandro Gonzalez-Ojeda, M.D., Ph.D. (2)  ·  A. Riaz, MD (1)  ·  Alex Molassiotis, MD (1)  ·  Alex Sia (1)  ·  Amal I. Melhem-Bertrandt, MD (1)  ·  Andrea Bezjak, MD, MSC, FRCPC (1)  ·  Arne Johan Norheim, MD Doctor phD (1)  ·  Aya H. M. Ahmad, Assistant professor, MD (1)  ·  Aya Moussa (1)  ·  Bernard Schachtel, MD (1)  ·  Bincy P Abraham, M.D., M.S. (1)

Results publications

PMID 26272769, PMID 11773155, PMID 12145072, PMID 12377323, PMID 12562658, PMID 15680647, PMID 16198982, PMID 16436839, PMID 16849762, PMID 19135415, PMID 19428297, PMID 19805683, PMID 20843504, PMID 21182781, PMID 21436683, PMID 21851346, PMID 21872708, PMID 22286518, PMID 22343090, PMID 22546966, PMID 22915657, PMID 22972538, PMID 23041302, PMID 23062719, PMID 23244208, PMID 23510951, PMID 23811424, PMID 23887247, PMID 24015953, PMID 24438599, PMID 24882606, PMID 25037960, PMID 25052410, PMID 25563879, PMID 25761431, PMID 25884778, PMID 25900659, PMID 25921377, PMID 26032041, PMID 26272768, PMID 26289588, PMID 26844757, PMID 26921245, PMID 26952945, PMID 27082959, PMID 27307177, PMID 27410922, PMID 27762434, PMID 27881103, PMID 28058142

NIH funding

2014 (2), U10CA037420 (2), 2009 (1), 2019 (1), U01DK065713 (1), U10CA031946 (1)